Clinical Trial Update: Performance and Safety of IRIDIUM GARZE in Blepharitis or Blepharconjunctivitis Adjuvant Treatment [NA]

View source ↗

Summary

This is a clinical trial update for IRIDIUM GARZE as adjuvant therapy for blepharitis and blepharoconjunctivitis. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blepharitis
• Blepharoconjunctivitis

Drugs mentioned

• IRIDIUM GARZE

Snippet

Sponsor: Fidia Farmaceutici s.p.a. | Conditions: Blepharitis, Blepharoconjunctivitis | NA | Status: RECRUITING